These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15649189)

  • 1. Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme.
    de Korte J; Van Onselen J; Kownacki S; Sprangers MA; Bos JD
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):35-41. PubMed ID: 15649189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective assessment of compliance with psoriasis treatment.
    Zaghloul SS; Goodfield MJ
    Arch Dermatol; 2004 Apr; 140(4):408-14. PubMed ID: 15096368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
    Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
    Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey.
    Dubertret L; Mrowietz U; Ranki A; van de Kerkhof PC; Chimenti S; Lotti T; Schäfer G;
    Br J Dermatol; 2006 Oct; 155(4):729-36. PubMed ID: 16965422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life.
    Katugampola RP; Hongbo Y; Finlay AY
    Br J Dermatol; 2005 Jun; 152(6):1256-62. PubMed ID: 15948990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.
    Augustin M; Krüger K; Radtke MA; Schwippl I; Reich K
    Dermatology; 2008; 216(4):366-72. PubMed ID: 18319601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
    Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional status and patient satisfaction: a comparison of ischemic heart disease, obstructive lung disease, and diabetes mellitus.
    Fan VS; Reiber GE; Diehr P; Burman M; McDonell MB; Fihn SD
    J Gen Intern Med; 2005 May; 20(5):452-9. PubMed ID: 15963172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in quality of life in persons with eczema and psoriasis after treatment in departments of dermatology.
    Wahl AK; Mørk C; Lillehol BM; Myrdal AM; Helland S; Hanestad BR; Moum T
    Acta Derm Venereol; 2006; 86(3):198-201. PubMed ID: 16710574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient education in Parkinson's disease: Formative evaluation of a standardized programme in seven European countries.
    Macht M; Gerlich C; Ellgring H; Schradi M; Rusiñol AB; Crespo M; Prats A; Viemerö V; Lankinen A; Bitti PE; Candini L; Spliethoff-Kamminga N; de Vreugd J; Simons G; Pasqualini MS; Thompson SB; Taba P; Krikmann U; Kanarik E
    Patient Educ Couns; 2007 Feb; 65(2):245-52. PubMed ID: 16965885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to treatment in patients with psoriasis vulgaris: Turkish experience.
    Gokdemir G; Ari S; Köşlü A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):330-5. PubMed ID: 18269601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
    Lecha M; Mirada A; López S; Artés M;
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
    Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
    Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of sexual life in patients with psoriasis.
    Sampogna F; Gisondi P; Tabolli S; Abeni D;
    Dermatology; 2007; 214(2):144-50. PubMed ID: 17341864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
    Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
    Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What are the objectives of moderate to severe psoriasis treatment?].
    Ortonne JP
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S281-4. PubMed ID: 18721665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in psoriasis improves after standardized administration of narrowband UVB phototherapy.
    Lim C; Brown P
    Australas J Dermatol; 2006 Feb; 47(1):37-40. PubMed ID: 16405481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.